Nonoperative versus operative treatment of obstructive jaundice in pancreatic cancer: cost and survival analysis.
Pancreatic carcinoma is complicated by malignant obstructive jaundice in 40-70% of cases. Patients frequently are old, debilitated, unresectable, and faced with a dismal prognosis. Invasive endoscopic and radiologic procedures in the inoperable patient can provide palliation without the need for surgery, in most cases. Few studies have compared nonoperative palliation with conventional surgical biliary enteric bypass procedures. In a retrospective study of patients with pancreatic carcinoma, we found no difference between operative and nonoperative treatment in survival, total hospitalization, or morbidity and mortality. Cost analysis revealed significant savings with nonoperative treatment.
Brandabur
J J
JJ
Department of Medicine, Virginia Mason Medical Center, Seattle, Washington.
Kozarek
R A
RA
Ball
T J
TJ
Hofer
B O
BO
Ryan
J A
JA
Traverso
L W
LW
Freeny
P C
PC
Lewis
G P
GP
D000368:Aged; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000150:complications / Q000191:economics* / Q000401:mortality; D002760:Cholangiopancreatography, Endoscopic Retrograde; D002779:Cholestasis / Q000209:etiology / Q000628:therapy*; D003362:Cost-Benefit Analysis; D004724:Endoscopy / Q000379:methods; D006801:Humans; D007902:Length of Stay / Q000191:economics; D008096:Lithotripsy / Q000379:methods; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000150:complications / Q000191:economics* / Q000401:mortality